1977•RadiologyRequires access

Metrizamide—CSF Contrast Medium

Joseph F. Sackett, Charles M. Strother, Charles E. Quaglieri, Manucher J. Javid, Allan B. Levin, Thomas A. Duff

Abstract

Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Metrizamide, Medicine, Contrast medium, Fluoroscopy, Contrast (vision), Radiology, Subarachnoid space, Nuclear medicine